Found: 63
Select item for more details and to access through your institution.
Efficacy of Atezolizumab Plus Bevacizumab–Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
- Published in:
- Current Oncology, 2024, v. 31, n. 10, p. 5821, doi. 10.3390/curroncol31100432
- By:
- Publication type:
- Article
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05444-z
- By:
- Publication type:
- Article
Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy.
- Published in:
- Journal of Gastroenterology, 2012, v. 47, n. 6, p. 686, doi. 10.1007/s00535-012-0555-6
- By:
- Publication type:
- Article
Phosphatidylinositol-phospholipase C2 regulates pattern-triggered immunity in Nicotiana benthamiana.
- Published in:
- Journal of Experimental Botany, 2020, v. 71, n. 16, p. 5027, doi. 10.1093/jxb/eraa233
- By:
- Publication type:
- Article
Comprehensive Identification of PTI Suppressors in Type III Effector Repertoire Reveals that Ralstonia solanacearum Activates Jasmonate Signaling at Two Different Steps.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 23, p. 5992, doi. 10.3390/ijms20235992
- By:
- Publication type:
- Article
Usefulness of a novel transarterial chemoinfusion plus external‐beam radiation therapy for advanced hepatocellular carcinoma with tumor thrombi in the inferior vena cava and right atrium: Case study.
- Published in:
- Cancer Reports, 2022, v. 5, n. 8, p. 1, doi. 10.1002/cnr2.1539
- By:
- Publication type:
- Article
Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast-enhanced ultrasound.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1471
- By:
- Publication type:
- Article
Therapeutic Outcomes and Prognostic Factors of Unresectable Intrahepatic Cholangiocarcinoma: A Data Mining Analysis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 5, p. 987, doi. 10.3390/jcm10050987
- By:
- Publication type:
- Article
Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21528-2
- By:
- Publication type:
- Article
The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 3, p. 1002, doi. 10.1245/s10434-013-3376-9
- By:
- Publication type:
- Article
Robust Effect of Hepatic Arterial Infusion Chemotherapy and Radiation Therapy on Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease.
- Published in:
- Internal Medicine, 2022, v. 61, n. 8, p. 1145, doi. 10.2169/internalmedicine.8154-21
- By:
- Publication type:
- Article
Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 7, p. 655, doi. 10.1111/hepr.14020
- By:
- Publication type:
- Article
Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real‐world data.
- Published in:
- Hepatology Research, 2023, v. 53, n. 2, p. 116, doi. 10.1111/hepr.13852
- By:
- Publication type:
- Article
The beneficial impact of metabolic dysfunction‐associated fatty liver disease on lenvatinib treatment in patients with non‐viral hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2023, v. 53, n. 2, p. 104, doi. 10.1111/hepr.13843
- By:
- Publication type:
- Article
High serum interleukin‐34 level is a predictor of poor prognosis in patients with non‐viral hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2019, v. 49, n. 9, p. 1046, doi. 10.1111/hepr.13350
- By:
- Publication type:
- Article
Prognostic impact of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation in patients with unresectable hepatocellular carcinoma: Comparison with TACE alone using decision‐tree analysis after propensity score matching
- Published in:
- Hepatology Research, 2019, v. 49, n. 8, p. 919, doi. 10.1111/hepr.13348
- By:
- Publication type:
- Article
Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysis.
- Published in:
- Hepatology Research, 2014, v. 44, n. 8, p. 837, doi. 10.1111/hepr.12192
- By:
- Publication type:
- Article
Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan.
- Published in:
- Hepatology Research, 2010, v. 40, n. 10, p. 989, doi. 10.1111/j.1872-034X.2010.00706.x
- By:
- Publication type:
- Article
Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C.
- Published in:
- Hepatology Research, 2010, v. 40, n. 9, p. 911, doi. 10.1111/j.1872-034X.2010.00699.x
- By:
- Publication type:
- Article
Suppression of DS1 Phosphatidic Acid Phosphatase Confirms Resistance to <i>Ralstonia solanacearum</i> in <i>Nicotiana</i><i> benthamiana</i>.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0075124
- By:
- Publication type:
- Article
Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0026840
- By:
- Publication type:
- Article
Virus-induced gene silencing in Solanum torvum.
- Published in:
- Journal of General Plant Pathology, 2022, v. 88, n. 1, p. 10, doi. 10.1007/s10327-021-01040-7
- By:
- Publication type:
- Article
Percutaneous Radiofrequency Ablation with or without Chemolipiodolization for Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1483, doi. 10.3390/jcm11061483
- By:
- Publication type:
- Article
Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4284, doi. 10.3390/cancers14174284
- By:
- Publication type:
- Article
Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092295
- By:
- Publication type:
- Article
Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5282, doi. 10.3390/cancers13215282
- By:
- Publication type:
- Article
Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4450, doi. 10.3390/cancers13174450
- By:
- Publication type:
- Article
Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2786, doi. 10.3390/cancers13112786
- By:
- Publication type:
- Article
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 646, doi. 10.3390/cancers13040646
- By:
- Publication type:
- Article
Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 160, doi. 10.3390/cancers13010160
- By:
- Publication type:
- Article
Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1867, doi. 10.3390/cancers12071867
- By:
- Publication type:
- Article
Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse Events.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1010, doi. 10.3390/cancers12041010
- By:
- Publication type:
- Article
The impact of curative conversion therapy aimed at a cancer‐free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 11, p. 12325, doi. 10.1002/cam4.5931
- By:
- Publication type:
- Article
First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 23, p. 8530, doi. 10.1002/cam4.4367
- By:
- Publication type:
- Article
Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 5, p. 2646, doi. 10.1002/cam4.2061
- By:
- Publication type:
- Article
Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 12, p. 1836, doi. 10.1002/cam4.548
- By:
- Publication type:
- Article
Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 4, p. 705, doi. 10.3350/cmh.2024.0372
- By:
- Publication type:
- Article
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 242, doi. 10.3350/cmh.2023.0102
- By:
- Publication type:
- Article
Telephone follow‐up contributes to improving adherence and treatment duration in patients with hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 7, p. 1140, doi. 10.1111/jgh.16168
- By:
- Publication type:
- Article
Letter to the Editor: DNA Purification-Free PCR from Plant Tissues.
- Published in:
- Plant & Cell Physiology, 2021, v. 62, n. 10, p. 1503, doi. 10.1093/pcp/pcab120
- By:
- Publication type:
- Article
Ralstonia solanacearum Type III Effector RipAC Targets SGT1 to Suppress Effector-Triggered Immunity.
- Published in:
- Plant & Cell Physiology, 2020, v. 61, n. 12, p. 2067, doi. 10.1093/pcp/pcaa122
- By:
- Publication type:
- Article
Ralstonia solanacearum Type III Effector RipAL Targets Chloroplasts and Induces Jasmonic Acid Production to Suppress Salicylic Acid-Mediated Defense Responses in Plants.
- Published in:
- Plant & Cell Physiology, 2018, v. 59, n. 12, p. 2576, doi. 10.1093/pcp/pcy177
- By:
- Publication type:
- Article
Clinical effects and safety of intra-arterial infusion therapy of cisplatin suspension in lipiodol combined with 5-fluorouracil versus sorafenib, for advanced hepatocellular carcinoma with macroscopic vascular invasion without extra-hepatic spread: A prospective cohort study
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 6, p. 1013, doi. 10.3892/mco.2017.1442
- By:
- Publication type:
- Article
The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 5, n. 1, p. 83, doi. 10.3892/mco.2016.879
- By:
- Publication type:
- Article
Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 1, p. 115, doi. 10.3892/mco.2014.435
- By:
- Publication type:
- Article
Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis.
- Published in:
- Molecular & Clinical Oncology, 2014, v. 2, n. 3, p. 393, doi. 10.3892/mco.2014.259
- By:
- Publication type:
- Article
Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 756, doi. 10.1159/000518612
- By:
- Publication type:
- Article
Increased Arterio-Portal Shunt Formation after Drug-Eluting Beads TACE for Hepatocellular Carcinoma.
- Published in:
- Oncology, 2020, v. 98, n. 8, p. 558, doi. 10.1159/000507262
- By:
- Publication type:
- Article
Dose and Location of Irradiation Determine Survival for Patients with Hepatocellular Carcinoma with Macrovascular Invasion in External Beam Radiation Therapy.
- Published in:
- Oncology, 2019, v. 96, n. 4, p. 192, doi. 10.1159/000495568
- By:
- Publication type:
- Article